Private Equity

Marina Temkin

Investors

How Foundry Group expands its network by backing emerging managers

Since launching its formal LP effort in 2016, Boulder, Colorado-based Foundry Group firm has backed dozens of emerging managers. These relationships have also helped the firm zero in on direct investments.

3 min read · 05 October 2020

Deals

Edtech sector has sights set on graduating with large exits

Investor interest in edtech is expected to continue in a post-pandemic world, according to Tory Patterson of edtech-focused Owl Ventures, who says that we will soon see some good IPO candidates.

5 min read · 01 October 2020

Investors

LPs anticipate rebound in Q2 valuations despite early concerns from covid-19

LPs’ fears of large markdowns in VC assets did not materialize. Valuations through Q2 are expected to either stay relatively flat or even increase, especially for late-stage focused managers.

5 min read · 14 September 2020

Managers

Healthcare-focused HLM advises patience for those new in the sector

Boston-based HLM Venture Partners has an extensive history in the sector and is currently raising its fifth $125m fund.

3 min read · 08 September 2020

Deals

Bill Reichert on his decision to invest in an unproven field of quantum computing

The Silicon Valley veteran talks about his investment in Rigetti and why he says there is a lot of excitement regarding the nascent field of quantum computing.

4 min read · 27 August 2020

Investors

Adams Street Partners relies on decades of VC investing to identify emerging managers

In 2016, the LP formed a dedicated early-stage venture capital fund by leveraging its existing VC program. It continues to re-up with long-term partners as it also adds one or two new GPs a year.

3 min read · 24 August 2020

Investors

Hamilton Lane's Miguel Luiña on why the growth segment will continue to thrive

The private markets advisory firm believes the pandemic has created even greater investment opportunities in the late-stage and growth equity sectors.

3 min read · 20 August 2020

Deals

Much more than covid-19 is behind the biotech boom

Appetite for biopharma is on the rise as investors want to back scientific advances and the recession-proof sector, and generalist VCs don’t want to miss out on potential outsized returns.

6 min read · 19 August 2020

Deals

Hims will likely not be going public via reverse merger with a SPAC

The online provider of personal healthcare will likely not be doing a reverse merger with a SPAC soon, according to a venture source.

2 min read · 17 August 2020

Deals

VC deal activity in healthcare reaches record levels

VC investment in biopharma and health tech continues to soar amid the covid-19 pandemic.

2 min read · 27 July 2020

Showing 11 to 20 of 218 results
1345…22